A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by University of Toronto
Sponsor:
Collaborator:
University Health Network, Toronto
Information provided by (Responsible Party):
Martine Puts, University of Toronto
ClinicalTrials.gov Identifier:
NCT02222259
First received: August 18, 2014
Last updated: September 8, 2014
Last verified: September 2014
  Purpose

The purpose of this study is to determine the feasibility of implementing a randomized controlled study of the intervention (Geriatric Assessment followed by an integrated care plan carried out by the multidisciplinary geriatric oncology team) designed to maintain/improve quality of life and functional status in older adults with advanced gastrointestinal, genitourinary or breast cancer referred for first line chemotherapy.

Secondarily, the study will investigate the impact of the Geriatric Assessment on the cancer treatment decision of the cancer specialist.


Condition Intervention
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Procedure: GA and Integrated Care Plan

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients (A GEM Study for Older Cancer Patients)

Resource links provided by NLM:


Further study details as provided by University of Toronto:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    We will measure quality of life with European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core version 30 items (EORTC QLQ C30)


Secondary Outcome Measures:
  • Impact of the Geriatric Assessment (GA) on the cancer treatment decision questionnaire [ Time Frame: 6 months ] [ Designated as safety issue: No ]

    The treating oncologist will be asked to indicate the cancer treatment plan prior to receiving the geriatric assessment results using a survey previously used in the study of Dr. Alibhai et al (Am J Clin Oncol. 2012 Aug;35(4):322-8.).

    After the GA the results will be send to the treating oncologist and after the physician will be asked to indicate whether or not and if yes how he/she modified the treatment plan based on the GA results


  • Functional status [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    We will measure functional status with the Older American Resources and Services Instrumental Activities of Daily Living questionnaire (7 items)


Estimated Enrollment: 60
Study Start Date: September 2014
Estimated Study Completion Date: October 2015
Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: GA and Integrated Care Plan
Participants allocated to the intervention group will be seen in the geriatric oncology clinic where they will be assessed using a geriatric assessment. Based on the issues identified in the geriatric assessment, a care plan will be developed with the participant to address the issues.
Procedure: GA and Integrated Care Plan
The intervention will consist of a Geriatric Assessment conducted by a multidisciplinary geriatric oncology team followed by an integrated care plan developed and implemented by the team for those issues identified in the assessment. The study intervention includes contact with the intervention team at 4 points in time during the study: at baseline (to conduct the assessment and develop the integrated care plan), 2-3 weeks by telephone after the clinic visit to evaluate if the plan needs adjustments, at 3 and 6 months (to evaluate the outcomes of the integrated care plan; i.e., did the patient follow all recommendations of the integrated care plan and did the plan lead to the desired outcomes for the problems identified?
No Intervention: Standard oncology care
Participants randomized to standard oncology care will receive usual care from their oncology team.

  Eligibility

Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of advanced (stage 3 or 4) Gastrointestinal, Genitourinary, or breast cancer
  • Referred for first-line chemotherapy
  • Ability to speak English
  • Physician estimated life expectancy >6 months
  • An Eastern Oncology Group Collaborative (ECOG) Performance Score of 0-2
  • Ability to provide informed consent

Exclusion Criteria:

  • Previous chemotherapy for current stage of disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02222259

Contacts
Contact: Martine Puts, RN, PhD (416) 978-6059 martine.puts@utoronto.ca

Locations
Canada, Ontario
Princess Margaret Cancer Centre Recruiting
Toronto, Ontario, Canada, M5T 2M9
Principal Investigator: Shabbir M Alibhai, MD MSc         
Sponsors and Collaborators
University of Toronto
University Health Network, Toronto
Investigators
Principal Investigator: Shabbir Alibhai, MD University Health Network, Toronto
Principal Investigator: Martine Puts, PhD University of Toronto
  More Information

No publications provided

Responsible Party: Martine Puts, Assistant Professor, University of Toronto
ClinicalTrials.gov Identifier: NCT02222259     History of Changes
Other Study ID Numbers: 14-7879-CE
Study First Received: August 18, 2014
Last Updated: September 8, 2014
Health Authority: Canada: Institutional Review Board

Keywords provided by University of Toronto:
Geriatric Oncology
Quality of Life
Comprehensive Geriatric Assessment
Functional Status
Chemotherapy
Older Adults

Additional relevant MeSH terms:
Breast Neoplasms
Gastrointestinal Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases
Digestive System Neoplasms
Digestive System Diseases
Gastrointestinal Diseases

ClinicalTrials.gov processed this record on October 19, 2014